Business

IntegraGen : reports 2020 revenue of €9.0 million, an increase of +10%, and a cash position of €5.0 million as of December 31, 2020

IntegraGen : reports 2020 revenue of €9.0 million, an increase of +10%, and a cash position of €5.0 million as of December 31,

Integragen SaJanuary 12, 20214
IntegraGen : reports 2020 revenue of €9.0 million, an increase of +10%, and a cash position of €5.0 million as of December 31, 2020

About this update from Integragen Sa

IntegraGen announced today its unaudited business figures for the year 2020. 2020 revenue amounted to 9.0 M € versus 8.1 M € in 2019, an increase of 10% over 12 months. Increased sequencing services reported for company's Evry lab and at outsourced platforms run by the company for the SeqOIA project and at the Institut Pasteur. Growth in sales also experienced with company's sequencing data interpretation software tools Mercury®, Sirius® and Galileo® Company generated positive operating cash flow throughout the year and obtained a French State Guaranteed Loan (PGE) of € 1.8 million. The company's cash position improved from €2.8 million at the beginning of the year to €5.0 million at the end of December. Click here to view press release

View stock analysis, news, and events for Integragen Sa

More from Integragen Sa

All Integragen Sa news →